GB0526247D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0526247D0
GB0526247D0 GB0526247A GB0526247A GB0526247D0 GB 0526247 D0 GB0526247 D0 GB 0526247D0 GB 0526247 A GB0526247 A GB 0526247A GB 0526247 A GB0526247 A GB 0526247A GB 0526247 D0 GB0526247 D0 GB 0526247D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0526247A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0526247A priority Critical patent/GB0526247D0/en
Publication of GB0526247D0 publication Critical patent/GB0526247D0/en
Priority to EP06841059.6A priority patent/EP1968549B1/en
Priority to BRPI0620063A priority patent/BRPI0620063B8/en
Priority to ARP060105668A priority patent/AR058591A1/en
Priority to PL10175382T priority patent/PL2359809T3/en
Priority to ES10175382T priority patent/ES2755032T3/en
Priority to IN3936DEN2015 priority patent/IN2015DN03936A/en
Priority to KR1020137004518A priority patent/KR20130024987A/en
Priority to PT101753820T priority patent/PT2359809T/en
Priority to PT68410596T priority patent/PT1968549E/en
Priority to AU2006328950A priority patent/AU2006328950B2/en
Priority to BR122019027412A priority patent/BR122019027412B8/en
Priority to EP10175382.0A priority patent/EP2359809B1/en
Priority to CNA2006800487961A priority patent/CN101346130A/en
Priority to ES06841059.6T priority patent/ES2492641T3/en
Priority to CN2013101523825A priority patent/CN103251929A/en
Priority to US12/158,345 priority patent/US20090004283A1/en
Priority to CA2631811A priority patent/CA2631811C/en
Priority to KR1020087014985A priority patent/KR101245919B1/en
Priority to KR1020137004520A priority patent/KR20130024988A/en
Priority to PCT/EP2006/012313 priority patent/WO2007071395A1/en
Priority to PE2006001665A priority patent/PE20071139A1/en
Priority to EP19188892.4A priority patent/EP3603623A1/en
Priority to KR1020137004517A priority patent/KR101458728B1/en
Priority to JP2008546248A priority patent/JP2009520727A/en
Priority to PL06841059T priority patent/PL1968549T3/en
Priority to RU2008129626/15A priority patent/RU2464972C2/en
Priority to KR1020147031146A priority patent/KR20140133968A/en
Priority to TW95148218A priority patent/TWI469788B/en
Priority to TW103107772A priority patent/TWI468172B/en
Priority to ZA200804629A priority patent/ZA200804629B/en
Priority to IL191842A priority patent/IL191842A0/en
Priority to MA31048A priority patent/MA30064B1/en
Priority to EC2008008560A priority patent/ECSP088560A/en
Priority to NO20082988A priority patent/NO20082988L/en
Priority to JP2013092845A priority patent/JP6239851B2/en
Priority to JP2014207464A priority patent/JP6178772B2/en
Priority to US14/516,016 priority patent/US20150037420A1/en
Priority to US14/977,801 priority patent/US20160120935A1/en
Priority to JP2016115579A priority patent/JP2016216467A/en
Priority to US15/873,473 priority patent/US20180140662A1/en
Priority to CL2018003398A priority patent/CL2018003398A1/en
Priority to US16/813,864 priority patent/US20200206306A1/en
Priority to US17/834,014 priority patent/US20220296675A1/en
Ceased legal-status Critical Current

Links

GB0526247A 2005-12-22 2005-12-22 Organic compounds Ceased GB0526247D0 (en)

Priority Applications (44)

Application Number Priority Date Filing Date Title
GB0526247A GB0526247D0 (en) 2005-12-22 2005-12-22 Organic compounds
KR1020147031146A KR20140133968A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
PCT/EP2006/012313 WO2007071395A1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
EP19188892.4A EP3603623A1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
ARP060105668A AR058591A1 (en) 2005-12-22 2006-12-20 FORMULATION OF SUSTAINED RELEASE THAT INCLUDES OCTREOTIDE AND TWO OR MORE POLYMACTIDE-COGLICOLID POLYMERS
BRPI0620063A BRPI0620063B8 (en) 2005-12-22 2006-12-20 sustained release pharmaceutical composition in the form of microparticles, usage, and administration kit
ES10175382T ES2755032T3 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
IN3936DEN2015 IN2015DN03936A (en) 2005-12-22 2006-12-20
KR1020137004518A KR20130024987A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
PT101753820T PT2359809T (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
PT68410596T PT1968549E (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
AU2006328950A AU2006328950B2 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
PE2006001665A PE20071139A1 (en) 2005-12-22 2006-12-20 SUSTAINED RELEASE FORMULATION INCLUDING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
EP10175382.0A EP2359809B1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
KR1020137004517A KR101458728B1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
ES06841059.6T ES2492641T3 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
CN2013101523825A CN103251929A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
US12/158,345 US20090004283A1 (en) 2005-12-22 2006-12-20 Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers
CA2631811A CA2631811C (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
KR1020087014985A KR101245919B1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
KR1020137004520A KR20130024988A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
EP06841059.6A EP1968549B1 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
BR122019027412A BR122019027412B8 (en) 2005-12-22 2006-12-20 sustained release pharmaceutical composition in the form of microparticles, process for preparing said microparticles, and administration kit
PL10175382T PL2359809T3 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
CNA2006800487961A CN101346130A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
JP2008546248A JP2009520727A (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide coglycolide polymers
PL06841059T PL1968549T3 (en) 2005-12-22 2006-12-20 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
RU2008129626/15A RU2464972C2 (en) 2005-12-22 2006-12-20 Composition with delayed release, including octreotide and two or more polylactide and glycolide copolymers
TW95148218A TWI469788B (en) 2005-12-22 2006-12-21 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
TW103107772A TWI468172B (en) 2005-12-22 2006-12-21 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
ZA200804629A ZA200804629B (en) 2005-12-22 2008-05-28 Sustained release formulation comprising octreotide and two or more polyactide-co-glycolide polymers
IL191842A IL191842A0 (en) 2005-12-22 2008-05-29 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
MA31048A MA30064B1 (en) 2005-12-22 2008-06-18 PROLONGED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO COPOLYMERS OF POLYLACTIDE-GLYCOLIDE OR MORE
EC2008008560A ECSP088560A (en) 2005-12-22 2008-06-19 FORMULATION OF SUSTAINED RELEASE THAT INCLUDES OCTREOTIDE AND TWO OR MORE POLYMACTIDE-CO-GLYCOLIDE POLYMERS
NO20082988A NO20082988L (en) 2005-12-22 2008-07-02 Sustained release formulation including octreotide and two or more polylactide co-glycolide polymers
JP2013092845A JP6239851B2 (en) 2005-12-22 2013-04-25 Sustained release formulation comprising octreotide and two or more polylactide coglycolide polymers
JP2014207464A JP6178772B2 (en) 2005-12-22 2014-10-08 Sustained release formulation comprising octreotide and two or more polylactide coglycolide polymers
US14/516,016 US20150037420A1 (en) 2005-12-22 2014-10-16 Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers
US14/977,801 US20160120935A1 (en) 2005-12-22 2015-12-22 Sustanined Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers
JP2016115579A JP2016216467A (en) 2005-12-22 2016-06-09 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
US15/873,473 US20180140662A1 (en) 2005-12-22 2018-01-17 Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers
CL2018003398A CL2018003398A1 (en) 2005-12-22 2018-11-29 Pharmaceutical sustained release composition comprising micro-particles. (application division 2013-03538).
US16/813,864 US20200206306A1 (en) 2005-12-22 2020-03-10 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
US17/834,014 US20220296675A1 (en) 2005-12-22 2022-06-07 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0526247A GB0526247D0 (en) 2005-12-22 2005-12-22 Organic compounds

Publications (1)

Publication Number Publication Date
GB0526247D0 true GB0526247D0 (en) 2006-02-01

Family

ID=35841071

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0526247A Ceased GB0526247D0 (en) 2005-12-22 2005-12-22 Organic compounds

Country Status (3)

Country Link
CN (1) CN101346130A (en)
GB (1) GB0526247D0 (en)
ZA (1) ZA200804629B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023016565A1 (en) * 2021-08-13 2023-02-16 江西济民可信集团有限公司 Microsphere suspension, microparticle formulation, and preparation method therefor

Also Published As

Publication number Publication date
CN101346130A (en) 2009-01-14
ZA200804629B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
GB0510390D0 (en) Organic compounds
GB0507575D0 (en) Organic compounds
GB0500435D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0508319D0 (en) Organic compounds
GB0505969D0 (en) Organic compounds
GB0507577D0 (en) Organic compounds
GB0505219D0 (en) Organic compounds
GB0507696D0 (en) Organic compounds
GB0504850D0 (en) Organic compounds
GB0507298D0 (en) Organic compounds
GB0504194D0 (en) Organic compounds
GB0504544D0 (en) Organic compounds
GB0510810D0 (en) Organic compounds
GB0508992D0 (en) Organic compounds
GB0511060D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0511063D0 (en) Organic compounds
GB0500683D0 (en) Organic compounds
GB0507695D0 (en) Organic compounds
GB0505541D0 (en) Organic compounds
GB0510585D0 (en) Organic compounds
GB0500020D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)